Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs1433318 | chr3:136666454 | C/T | 0.000469 | 177 | 22.15 | 27.33 | 23.03 | KM Plot |
PCPG | rs1433319 | chr3:136666599 | A/G | 0.000469 | 177 | 22.15 | 27.33 | 23.03 | KM Plot |
PCPG | rs143347140 | chr13:27131826 | G/T | 0.000143 | 177 | 25.77 | 24.37 | 13.17 | KM Plot |
PCPG | rs143405823 | chr12:56723719 | T/C | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs143532254 | chr13:114168552 | T/TC | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs143662042 | chr7:105147639 | C/T | 5.04E-5 | 178 | 20.17 | 28.95 | 2.28 | KM Plot |
PCPG | rs143702574 | chr11:18144836 | T/A | 3.28E-5 | 177 | 27.23 | 24.1 | 6.7 | KM Plot |
PCPG | rs143746957 | chr15:43374328 | ACT/A | 2.31E-14 | 177 | 25.87 | 24.53 | 3.17 | KM Plot |
PCPG | rs143797020 | chr10:69732020 | G/A | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs143798139 | chr16:90026005 | C/A | 1.26E-8 | 172 | 25.67 | 20.2 | 6.62 | KM Plot |
PCPG | rs143838827 | chr17:2102962 | G/A | 0.000351 | 177 | 25.97 | 16.32 | 25.62 | KM Plot |
PCPG | rs143935888 | chr16:88680345 | A/AG | 0.000383 | 174 | 25.53 | 24.35 | 14.47 | KM Plot |
PCPG | rs143979396 | chr15:39761449 | TA/T | 0.000433 | 176 | 24.85 | 27.43 | 26.33 | KM Plot |
PCPG | rs144039725 | chr7:76711319 | G/A | 0.000314 | 172 | 25.67 | 24.53 | 14.57 | KM Plot |
PCPG | rs144124512 | chr20:6010524 | C/CA | 0 | 176 | 25.53 | 22.63 | 2.93 | KM Plot |